Functional analysis of the proximal CCR5 promoter

AIDS Research and Human Retroviruses

Volumn 14, Issue 17, 1998, Pages 1509-1519

  Liu, Rong ^a   Zhao, Xiuqing ^a   Gurney, Theresa A ^a   Landau, Nathaniel R ^a,b  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TATA BINDING PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BINDING SITE; GENE ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; T LYMPHOCYTE;

EID: 0032553363     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.1509     Document Type: Article

References (53)

1. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al.: CC CKR5: A Ranles, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272: 1955-1958.
2. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, et al.: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
3. Deng D, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al.: Identification of a maor co-receptor for primary isolates of HIV-1. Nature (London) 1996;381:661-666.
4. Dragic T, Litwin V, Allaway GP, Martin SR, Huang Y, Nagashima KA, et al.: HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 1996;381: 667-673.
5. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, et al.: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
6. Chen Z, Zhou P, Ho DD, Landau NR, and Marx PA: Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997;71:2705-2714.
7. Baba M, Imai T, Nishimura M, Kakizaki M, Takagi S, Hieshima K, et al.: Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC. J Biol Chem 1997;272:14893-14898.
8. Bonini JA, Martin SK, Dralyuk F, Roe MW, Philipson LH, and Steiner DF: Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. DNA Cell Biol 1997; 16:1249-1256.
9. Charo IF, Myers SJ, Herman A, Franci C, Connolly AJ, and Coughlin SR: Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994;91:2752-2756.
10. Greaves DR, Wang W, Dairaghi DJ, Dieu MC, Saint-Vis B, Franz-Bacon K, et al.: CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3alpha and is highly expressed in human dendritic cells. J Exp Med 1997;186:837-844.
11. Neote K, DeGregorio D, Mak JY, Horuk R, and Schall TJ: Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993;72:415-425.
12. Nibbs RJB, Wylie S, Pragnell IB, and Graham GJ: Cloning and characterization of a novel murine beta chemokine receptor, D6. Comparison to three other related macrophage inflammatory protein-1alpha receptors, CCR-1 CCR-3, and CCR-5. J Biol Chem 1997;272:12495-12504.
13. Power CA, Meyer A, Nemeth K, Bacon KB, Hoogewerf AJ, Proudfoot AE, et al.: Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995;270:19495-19500.
14. Raport CJ, Gosling J, Schweickart VL, Gray PW, and Charo IF: Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha. J Biol Chem 1996;271:17161-17166.
15. Samson M, Labbe O, Mollereau C, Vassart G, and Parmentier M: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996;35:3362-3367.
16. Roos RS, Loetscher M, Legler DF, Clark-Lewis I, Baggiolini M, and Moser B: Identification of CCR8, the receptor for the human CC chemokine I-309. J Biol Chem 1997;272:17251-17254.
17. Yoshie O, Imai T, and Nomiyama H: Novel lymphocyte-specific CC chemokines and their receptors. J Leukocyte Biol 1997;62: 634-644.
18. Samson M, Soularue P, Vassart G, and Parmentier M: The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 1996;36:522-526.
19. Federspiel B, Melhado IG, Duncan AM, Delaney A, Schappert K, Clark-Lewis I, et al.: Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 1996;16:707-712.
20. Ahuja SK, Ozcelik T, Milatovitch A, Francke U, and Murphy PM: Molecular evolution of the human interleukin-8 receptor gene cluster. Nature Genet 1992;2:31-36.
21. He J, Chen Y, Farzan M, Choe H, Ohagen A, Gartner S, et al.: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (London) 1997;385:645-649.
22. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, et al.: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature (London) 1996;384: 179-183.
23. Wu L, LaRosa G, Kassam N, Gordon CJ, Heath H, Ruffing N, et al.: Interaction of chemokine receptor CCR5 with its ligands: Multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med 1997;186:1373-1381.
24. Bleul CC, Wu L, Hoxie JA, Springer TA, and Mackay CR: The HIV coreceptors CXVR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997;94:1925-1930.
25. Di Marzio P, Tse J, and Landau NR: Chemokine receptor regulation and HIV-1 tropism in monocytes/macrophages. AIDS Res Hum Retroviruses 1998;14:129-138.
26. Levine BL, Mosca JD, Riley JL, Carroll RG, Vahey MT, Jagodzinski LL, et al.: Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 1996;272:1939-1943.
27. Carroll RG, RIley JL, Levine BL, Feng Y, Kaushal S, Ritchey DW, et al.: Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science 1997;276: 273-276.
28. Riley JL, Carroll RG, Levine BL, Bernstein W, St Louis DC, Weislow OS, et al.: Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J Immunol 1997;158: 5545-5553.
29. Mummidi S, Ahuja SS, McDaniel BL, and Ahuja SK: The human CC chemokine receptor 5 (CCR5) gene. Multiple transcripts with 5′-end heterogeneity, dual promoter usage, and evidence for polymorphisms within the regulatory regions and noncoding exons. J Biol Chem 1997;272:30662-30671.
30. Moriuchi H, Moriuchi M, and Fauci AS: Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. J Immunol 1997;159:5441-5449.
31. Guignard F, Combadiere C, Lee Tiffany H, and Murphy PM: Gene organization and promoter function for CC chemokine receptor 5 (CCR5). J Immunol 1998;160:985-992.
32. Innis MA, Gelfand DH, Sninsky JJ, and White TJ: PCR Protocols: A Guide to Methods and Applications. Academic Press, San Diego, California, 1990.
33. Murphy PM: The molecular biology of the leukocyte chemoattractant receptors. Annu Rev Immunol 1994;12:593-633
34. Lusso P, Cocchi F, Balotta C, Markham PD, Louie A, Farci P, et al.: Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): Failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J Virol 1995;69:3712-3720.
35. Bucher P: Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol 1990;212:563-578.
36. Gordon J, Wasylyk B, Buchwalder A, Sassone-Corsi P, Kedinger C, and Chambon P: Promoter sequences of eukaryotic protein-coding genes. Science 1980;209:1405-1414.
37. Ghosh P, Tan TH, Rice NR, Sica A, and Young HA: The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65. Proc Natl Acad Sci USA 1993;90:1696-1700.
38. Lai JH, Horvath G, Subleski J, Bruder J, Ghosh P, and Tan TH: RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol Cell Biol 1995;15: 4260-4271.
39. Civil A, Bakker A, Rensink I, Doerre S, Aarden LA, and Verweij CL: Nuclear appearance of a factor that binds the CD28 response element within the interleukin-2 enhancer correlates with interleukin-2 production. J Biol Chem 1996;271:8321-8327.
40. Fraser JD, Irving BA, Crabtree GR, and Weiss A: Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991;251:313-316.
41. Civil A and Verweij CL: Regulation of IL2 gene transcription via the T-cell accessory molecule CD28. Res Immunol 1995;146: 158-164.
42. Himes SR, Coles LS, Reeves R, and Shannon MF: High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters. Immunity 1996;5:479-489.
43. Fraser JD and Weiss A: Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol Cell Biol 1992; 12:4357-5363.
44. Ivashkiv LB: Cytokines and STATs: How can signals achieve specificity. Cell 1995;3:1-4.
45. Rooney JW, Sun YL, Glimcher LH, and Hoey T: Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol 1995;15: 6299-6310.
46. O'Brien TR, Winkler C, Dean M, Nelson JA, Carrington M, Michael NL, et al.: HIV-1 infection in a man homozygous for CCR5 delta 32. Lancet 1997;349:1219. [Letter]
47. Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C, and Group SS: HIV-1 infection in an individual homozygous for CCR5delta32. Lancet 1997;349:1210-1220.
48. Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx D, et al.: The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nature Med 1997; 3:338-340.
49. Huang Y, Paxton WA, Wolinsky SM, Neumann AU, Zhang L, He T, et al.: The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nature Med 1996;2:1240-1243.
50. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al.: Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 1996;273:1856-1862.
51. Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, et al.: CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997;185:1681-1689.
52. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, et al.: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-965.
53. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, et al.: A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med 1998;4:350-353.